Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.12
Delayed Data
As of Jul 22
 +0.04 / +3.70%
Today’s Change
0.58
Today|||52-Week Range
1.82
+16.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues24.0K0.000.000.00
 
 
Cost of Goods Sold2.7K0.000.000.00
 
 
Depreciation And Amortization16.7K17.6K17.6K19.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.6K-17.6K-17.6K-19.0K
 
 
 
 
 
General Expenses2.1M1.6M1.7M1.8M
 
 
 
 
 
Research And Development1.2M942.3K1.0M1.0M
 
 
 
 
 
Total Operating Expenses2.1M1.6M1.7M1.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.1M-1.6M-1.7M-1.8M
 
 
 
 
 
Extraordinary Credit0.0035.7K10.2K--
 
 
 
Extraordinary Charge-11.5K0.000.00-1.8K
 
 
 
Interest Expense On Debt24.5K24.5K8.9K8.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.1M-1.6M-1.7M-1.8M
 
 
 
 
 
Net Income-2.1M-1.6M-1.7M-1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.4M32.4M32.4M40.2M
 
 
 
 
 
Shares To Calculate EPS Diluted32.4M32.4M32.4M40.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.05-$0.05-$0.04
 
 
 
 
 
EPS Diluted-$0.06-$0.05-$0.05-$0.04